Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 28;11(6):1425-1442.
doi: 10.14218/JCTH.2023.00320. Epub 2023 Aug 15.

Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)

Hong You  1 , Fusheng Wang  2 , Taisheng Li  3 , Xiaoyuan Xu  4 , Yameng Sun  1 , Yuemin Nan  5 , Guiqiang Wang  4 , Jinlin Hou  6 , Zhongping Duan  7 , Lai Wei  8 , Jidong Jia  1 , Hui Zhuang  9 ; Chinese Society of Hepatology, Chinese Medical Association; Chinese Society of Infectious Diseases, Chinese Medical Association
Affiliations

Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)

Hong You et al. J Clin Transl Hepatol. .

Abstract

To facilitate the achieving of the goal of "eliminating viral hepatitis as a major public health threat by 2030" set by the World Health Organization, the Chinese Society of Hepatology together with the Chinese Society of Infectious Diseases (both are branches of the Chinese Medical Association) organized a panel of experts and updated the guidelines for prevention and treatment of chronic hepatitis B in China (version 2022). With the support of available evidence, this revision of the guidelines focuses on active prevention, large scale testing, and expansion of therapeutic indication of chronic hepatitis B with the aim of reducing the hepatitis B related disease burden.

Keywords: Chronic hepatitis B; Guideline; Prevention; Treatment.

PubMed Disclaimer

Conflict of interest statement

HY and YN have been editorial board members of Journal of Clinical and Translational Hepatology, FW, JH, LW and JJ have been executive associate editors of Journal of Clinical and Translational Hepatology. The other authors have no conflict of interests related to this publication.

Figures

Fig. 1
Fig. 1. Indications for antiviral therapy of chronic HBV infection.
(a) HBV-related extrahepatic manifestations: glomerulonephritis, vasculitis, etc.; (b) Exclude other causes of ALT elevation: infection with other pathogens, history of taking drugs or poisons, history of alcohol consumption, lipid metabolism disorder, autoimmune disorder, liver congestion or vascular disease, genetic and metabolic liver injury, systemic disease, etc.; (c) NAs: ETV, TDF, TAF or TMF; (d) NAs: ETV, TDF or TAF. HBV, hepatitis B virus; HBsAg, hepatitis B surface antigen; HCC, hepatocellular carcinoma; DAA, direct-acting agents; Nas, nucleoside (acid) analogs; ALT, alanine aminotransferase; ULN, upper limit of normal; Peg-IFN-α, pegylated interferon alpha.
See this image and copyright information in PMC

References

    1. Chinese Society of Infectious Diseases, Chinese Medical Association; Chinese Society of Hepatology, Chinese Medical Association The guidelines of prevention and treatment for chronic hepatitis B (2019 version) Zhonghua Gan Zang Bing Za Zhi. 2019;27(12):938–961. doi: 10.3760/cma.j.issn.1007-3418.2019.12.007. - DOI - PubMed
    1. World Health Organization. Global hepatitis report, 2017. Available from: https://www.who.int/publicationos/i/item/9789241565455.
    1. Polaris Observatory Collaborators. HBV progress towards coverage targets. Available from: http://cdafound.org/polaris-countries-dashboard/
    1. Accountability for the global health sector strategies 2016–2021: actions for impact. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Available from: https://apps.who.int/iris/bitstream/handle/10665/342808/9789240030985-en....
    1. Cui F, Shen L, Li L, Wang H, Wang F, Bi S, et al. Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China. Emerg Infect Dis. 2017;23(5):765–772. doi: 10.3201/eid2305.161477. - DOI - PMC - PubMed